Abaxis, Inc. to Present at Ninth Annual Needham & Company Growth Conference
06 1월 2007 - 3:56AM
PR Newswire (US)
UNION CITY, Calif., Jan. 5 /PRNewswire-FirstCall/ -- ABAXIS, Inc.
(NASDAQ:ABAX), a medical products company manufacturing
point-of-care blood analysis systems, announced today that Clint
Severson, CEO and President, will present at the Ninth Annual
Needham & Company Growth Conference on Friday, January 12, 2007
at 9:30 a.m. ET. The conference will be held at the New York Palace
Hotel in New York, New York. About Abaxis Abaxis develops,
manufactures and markets portable blood analysis systems for use in
any veterinary or human patient-care setting to provide clinicians
with rapid blood constituent measurements. The system consists of a
compact, 6.9 kilogram (15 pounds), portable analyzer and a series
of single-use plastic discs, called reagent discs that contain all
the chemicals required to perform a panel of up to 13 tests on
veterinary patients and 14 tests on human patients. The system can
be operated with minimal training and performs multiple routine
tests on whole blood, serum or plasma samples. The system provides
test results in less than 14 minutes with the precision and
accuracy equivalent to a clinical laboratory analyzer. Contact:
Clint Severson Lytham Partners, LLC Chief Executive Officer Joe
Dorame, Joe Diaz & Robert Blum ABAXIS, Inc. 602-889-9700
510-675-6500 DATASOURCE: ABAXIS, Inc. CONTACT: Clint Severson,
Chief Executive Officer of ABAXIS, Inc., +1-510-675-6500; or Joe
Dorame, Joe Diaz or Robert Blum, all of Lytham Partners, LLC,
+1-602-889-9700, for ABAXIS, Inc.
Copyright
Abaxis, Inc. (delisted) (NASDAQ:ABAX)
과거 데이터 주식 차트
부터 9월(9) 2024 으로 10월(10) 2024
Abaxis, Inc. (delisted) (NASDAQ:ABAX)
과거 데이터 주식 차트
부터 10월(10) 2023 으로 10월(10) 2024
Abaxis, Inc. (delisted) (나스닥)의 실시간 뉴스: 최근 기사 0
More Abaxis (MM) News Articles